Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Prospective Study of the Miromatrix External Liver Assist Product (miroliverELAP®) for Liver Support in Adults With Acute Liver Failure.

NCT06285253 is registered in ClinicalTrials.gov with Miromatrix Medical Inc. as lead sponsor.

NCT NCT06285253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06285253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Prospective Study of the Miromatrix External Liver Assist Product (miroliverELAP®) for Liver Support in Adults With Acute Liver Failure.
Lead sponsor
Miromatrix Medical Inc.
Phase
Phase 1
Overall status
Completed
Start date
October 5, 2024
Completion date
January 22, 2026
Enrollment
10 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

acute alcoholic hepatitis, acute liver failure, acute liver injury, drug induced, acute on chronic liver failure (aclf)